HEMANGEOL Trademark

Trademark Overview

On Tuesday, February 4, 2014, a trademark application was filed for HEMANGEOL with the United States Patent and Trademark Office. The USPTO has given the HEMANGEOL trademark a serial number of 86183672. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, January 10, 2025. This trademark is owned by PIERRE FABRE DERMATOLOGIE. The HEMANGEOL trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for treating hemangioma
hemangeol

General Information

Serial Number86183672
Word MarkHEMANGEOL
Filing DateTuesday, February 4, 2014
Status800 - REGISTERED AND RENEWED
Status DateFriday, January 10, 2025
Registration Number4611446
Registration DateTuesday, September 23, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements

Goods and ServicesMedicines for treating hemangioma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 14, 2014
Primary Code005
First Use Anywhere DateMonday, May 19, 2014
First Use In Commerce DateMonday, May 19, 2014

Trademark Owner History

Party NamePIERRE FABRE DERMATOLOGIE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBOULOGNE 92100
FR
Party NamePIERRE FABRE DERMATOLOGIE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBOULOGNE 92100
FR
Party NamePIERRE FABRE DERMATOLOGIE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBOULOGNE 92100
FR

Trademark Events

Event DateEvent Description
Monday, March 24, 2014NON-FINAL ACTION WRITTEN
Friday, February 7, 2014NEW APPLICATION ENTERED
Friday, February 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 17, 2014ASSIGNED TO EXAMINER
Monday, March 24, 2014NON-FINAL ACTION E-MAILED
Monday, March 24, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 1, 2014EXAMINER'S AMENDMENT ENTERED
Tuesday, April 1, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 1, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, April 1, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 22, 2014ASSIGNED TO LIE
Thursday, April 24, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 28, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, September 23, 2014REGISTERED-PRINCIPAL REGISTER
Monday, September 23, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 22, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 28, 2014USE AMENDMENT FILED
Monday, August 18, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, August 18, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 20, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 21, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 15, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 28, 2020TEAS SECTION 8 & 15 RECEIVED
Thursday, October 15, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 15, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, September 23, 2024TEAS SECTION 8 & 9 RECEIVED
Friday, January 10, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 10, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, January 10, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, January 10, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, September 23, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

hemangeol hemangioma treating medicines